CN106632484A - 一种替诺福韦艾拉酚胺的制备方法 - Google Patents
一种替诺福韦艾拉酚胺的制备方法 Download PDFInfo
- Publication number
- CN106632484A CN106632484A CN201710005963.4A CN201710005963A CN106632484A CN 106632484 A CN106632484 A CN 106632484A CN 201710005963 A CN201710005963 A CN 201710005963A CN 106632484 A CN106632484 A CN 106632484A
- Authority
- CN
- China
- Prior art keywords
- preparation
- pmpa
- chinese mugwort
- draws
- phenol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
- C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710005963.4A CN106632484B (zh) | 2017-01-05 | 2017-01-05 | 一种替诺福韦艾拉酚胺的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710005963.4A CN106632484B (zh) | 2017-01-05 | 2017-01-05 | 一种替诺福韦艾拉酚胺的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106632484A true CN106632484A (zh) | 2017-05-10 |
CN106632484B CN106632484B (zh) | 2020-06-12 |
Family
ID=58844156
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710005963.4A Active CN106632484B (zh) | 2017-01-05 | 2017-01-05 | 一种替诺福韦艾拉酚胺的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106632484B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107522743A (zh) * | 2017-09-30 | 2017-12-29 | 深圳科兴生物工程有限公司 | 一种半富马酸替诺福韦艾拉酚胺工业化连续生产方法 |
CN110627832A (zh) * | 2019-10-07 | 2019-12-31 | 江西农业大学 | 一种氧化法合成替诺福韦艾拉酚胺的制备方法 |
CN111484528A (zh) * | 2019-01-25 | 2020-08-04 | 上海清松制药有限公司 | 一种替诺福韦艾拉酚胺中间体的制备方法 |
CN111484527A (zh) * | 2019-01-25 | 2020-08-04 | 上海清松制药有限公司 | 一种替诺福韦艾拉酚胺中间体的制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104230985A (zh) * | 2014-09-01 | 2014-12-24 | 北京天弘天达医药科技有限公司 | (s)-2-[(s)-(4-硝基-苯氧基)-苯氧基-磷酰基氨基]丙酸异丙酯的制备方法 |
WO2015161781A1 (zh) * | 2014-04-21 | 2015-10-29 | 四川海思科制药有限公司 | 一种核苷类似物及其中间体的制备方法 |
CN105131038A (zh) * | 2015-06-30 | 2015-12-09 | 浙江天顺生物科技有限公司 | 一种taf的制备方法 |
-
2017
- 2017-01-05 CN CN201710005963.4A patent/CN106632484B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015161781A1 (zh) * | 2014-04-21 | 2015-10-29 | 四川海思科制药有限公司 | 一种核苷类似物及其中间体的制备方法 |
CN104230985A (zh) * | 2014-09-01 | 2014-12-24 | 北京天弘天达医药科技有限公司 | (s)-2-[(s)-(4-硝基-苯氧基)-苯氧基-磷酰基氨基]丙酸异丙酯的制备方法 |
CN105131038A (zh) * | 2015-06-30 | 2015-12-09 | 浙江天顺生物科技有限公司 | 一种taf的制备方法 |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107522743A (zh) * | 2017-09-30 | 2017-12-29 | 深圳科兴生物工程有限公司 | 一种半富马酸替诺福韦艾拉酚胺工业化连续生产方法 |
CN111484528A (zh) * | 2019-01-25 | 2020-08-04 | 上海清松制药有限公司 | 一种替诺福韦艾拉酚胺中间体的制备方法 |
CN111484527A (zh) * | 2019-01-25 | 2020-08-04 | 上海清松制药有限公司 | 一种替诺福韦艾拉酚胺中间体的制备方法 |
CN110627832A (zh) * | 2019-10-07 | 2019-12-31 | 江西农业大学 | 一种氧化法合成替诺福韦艾拉酚胺的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN106632484B (zh) | 2020-06-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106632484A (zh) | 一种替诺福韦艾拉酚胺的制备方法 | |
CN104817593B (zh) | 半富马酸替诺福韦艾拉酚胺关键中间体的合成工艺 | |
CN107021984B (zh) | 一种taf核苷衍生物的制备方法及其中间体 | |
CN102985416A (zh) | 制备凝血酶特异性抑制剂的方法 | |
CN105541844B (zh) | 一种高纯度利拉利汀的简易制备方法 | |
CN102584795A (zh) | 一种克里唑替尼的制备方法 | |
CN104628773A (zh) | (r)-9-[2-(磷酰苯酚基甲氧基)丙基]腺嘌呤的制备方法 | |
CN105330700A (zh) | 富马酸替诺福韦艾拉酚胺杂质的制备方法 | |
CN111635434B (zh) | 1-丙基磷酸环酐的合成方法 | |
CN104672281B (zh) | 一种制备高纯富马酸替诺福韦二吡呋酯的方法 | |
Reddy et al. | Sulfonic acid functionalized hyper-cross-linked polymer: An efficient heterogeneous acid catalyst for the synthesis of N-containing bisphosphonates | |
CN105753840A (zh) | 一种达比加群酯中间体的合成方法 | |
CN110372749A (zh) | 一种丙酚替诺福韦关键中间体一苯基pmpa的制备方法 | |
CN105622671A (zh) | 一种可工业化大生产富马酸替诺福韦二吡呋酯的制备方法 | |
CN107098936A (zh) | 一种taf核苷衍生物的制备方法 | |
CN110305163A (zh) | 替诺福韦艾拉酚胺半富马酸盐的制备方法 | |
CN101490070A (zh) | 由五氯化磷和dmf产生副产物磷酰氯以及其通过转变成vilsmeier-haack试剂在氯化反应中的应用 | |
Mikołajczyk et al. | A new efficient procedure for asymmetric synthesis of α-aminophosphonic acids via addition of lithiated bis (diethylamino) phosphine borane complex to enantiopure sulfinimines | |
CN109970832B (zh) | 一种炔基修饰的脱氧腺苷亚磷酰胺单体及其制备方法 | |
CN101605802A (zh) | 双膦酸及其盐的制备方法 | |
CN111574567B (zh) | 刚性杂环化合物及其制备方法和用途和含膦磺酰胺化合物及其制备方法 | |
CN109134569B (zh) | 一种单磷酸阿糖腺苷的生产工艺 | |
CN113024521B (zh) | 一种制备恩曲替尼的方法 | |
JP3901321B2 (ja) | リボフラビン−5’−リン酸またはそのナトリウム塩の製造法 | |
CN109627262A (zh) | 对甲苯磺酰氧甲基亚甲基二膦酸四乙酯及其制备方法、泰诺福韦的杂质及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CB02 | Change of applicant information |
Address after: 200120 room 1415, 218 Haiqu Road, China (Shanghai) pilot Free Trade Zone, Pudong New Area, Shanghai Applicant after: Shanghai HouBo Biotechnology Co., Ltd Address before: 200120 Shanghai city Pudong New Area Tianxiong road 588 Lane 1-28 No. 5 building five layer Applicant before: SHANGHAI HOPE CHEM Co.,Ltd. |
|
CB02 | Change of applicant information | ||
CP03 | Change of name, title or address |
Address after: 200120 room 1415, 218 Haiqu Road, China (Shanghai) pilot Free Trade Zone, Pudong New Area, Shanghai Patentee after: Shanghai HouBo Biotechnology Co., Ltd Address before: 200120 Shanghai city Pudong New Area Tianxiong road 588 Lane 1-28 No. 5 building five layer Patentee before: SHANGHAI HOPE CHEM Co.,Ltd. |
|
CP03 | Change of name, title or address | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200817 Address after: NO.402, building 6, Fenghuang Science Park, No.8, Huangguan Road, high tech Zone, Anqing City, Anhui Province Patentee after: ANQING DUOHUI BIOTECHNOLOGY Co.,Ltd. Address before: 200120 room 1415, 218 Haiqu Road, China (Shanghai) pilot Free Trade Zone, Pudong New Area, Shanghai Patentee before: Shanghai HouBo Biotechnology Co., Ltd |
|
TR01 | Transfer of patent right |